Kyle Lefkoff, Director at ARRAY BIOPHARMA INC (ARRY), sold 47,000 shares at $8.92 ($401K) on 2017-03-31, disclosed to the SEC on 2017-04-04.
Open-market sale of $401k ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,000 | $0 | 0.0% |
| 2 | $8.92 | 45,000 | $401K | 100.0% |
| Total | $8.54 avg | 47,000 | $401K | 100% |
| Filing → |
| ARRY | SELL | 2018-02-12 | $1.7M | — | Filing → |
| ARRY | SELL | 2017-09-29 | $957K | — | Filing → |
| MGEN | SELL | 2017-03-13 | $83K | — | Filing → |